Free Trial

Amgen (AMGN) SEC Filings & 10K Form

Amgen logo
$310.78 +2.72 (+0.88%)
Closing price 04:00 PM Eastern
Extended Trading
$309.15 -1.63 (-0.52%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amgen SEC Filings

DateFilerForm TypeView
02/21/2025
7:06 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
7:07 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:27 PM
Amgen (Subject)
REESE DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
7:59 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
1:25 PM
Amgen (Subject)
Santos Esteban (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
8:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:01 PM
Amgen (Subject)
Gordon Murdo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
8:52 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:54 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
11:53 AM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:05 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:48 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:37 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:38 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:41 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:45 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:46 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:20 PM
Amgen (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/13/2024
4:44 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:41 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:00 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:23 PM
Amgen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/04/2024
6:26 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:27 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:28 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:31 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:32 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:33 PM
Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:22 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
6:23 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:24 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:25 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:17 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
5:59 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:00 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
05/09/2024
6:03 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:04 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:05 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:06 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:08 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:56 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:57 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:58 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:31 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:32 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:33 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:34 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:35 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:37 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:39 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:25 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:48 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:17 PM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
6:18 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:19 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:20 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:22 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:23 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:24 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:25 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:59 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:00 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:01 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
7:44 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:51 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:53 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:54 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:55 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:04 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:05 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:07 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:09 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:10 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:11 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:12 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out (Ad)

This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth protection guide shows you how to use Trump's vision to lock down your savings—your freedom, your future. Plus, for a few lucky individuals, we're honoring Trump's historic return with an exclusive free gift.

03/20/2024
6:59 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:00 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:34 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:25 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:26 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:29 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMGN) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners